Results 91 to 100 of about 31,412 (299)
Role of Septal Myectomy in Pediatric Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy is a prevalent cause of sudden cardiac death among young people. This distinctive genetic condition can manifest at any age from infancy to adulthood.
Sameh M. Said
doaj +1 more source
The impact of maternal congenital heart disease on pregnancy outcomes in Malta - a retrospective study [PDF]
Background: Most female patients with congenital heart disease (CHD) are becoming pregnant. Maternal CHD can have a negative impact on mother and foetus.
Aquilina, Oscar +5 more
core +3 more sources
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk +12 more
wiley +1 more source
Evolving management for critical pulmonary stenosis in neonates and young infants [PDF]
Over the years, management of critical pulmonary stenosis in young infants has evolved from surgical reconstruction of the right ventricular outflow tract and closed pulmonary valvotomy to transcatheter balloon valvoplasty.
Chau, AKT +4 more
core +1 more source
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li +12 more
wiley +1 more source
Pathology of Left Ventricular Outflow Tract Obstruction [PDF]
Lesions causing obstruction to the outflow of blood from the left ventricle may reside in the ascending aorta, the aortic valve, or the outflow tract of the left ventricle. Conditions involving the ascending aorta are usually congenital, and designated as supravalvular aortic stenosis. A tendency is present for this condition to be associated
openaire +2 more sources
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Background: Right ventricular involvement in hypertrophic cardiomyopathy is uncommon. This study aimed to evaluate clinical outcomes of the modified septal myectomy in patients diagnosed with biventricular hypertrophic cardiomyopathy (BHCM), a subject ...
Tong Tan +10 more
doaj +1 more source
Background Infective endocarditis (IE) after transcatheter pulmonary valve implantation (TPVI) in dysfunctioning right ventricular outflow tract conduits has evoked growing concerns.
Mohammad Abdelghani +10 more
doaj +1 more source
Risk factors for paravalvular leak after transcatheter aortic valve replacement [PDF]
Objective. To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation (TAVI) in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method. Methods.
Pollari, Francesco
core

